Qrativ, a joint venture of Mayo Clinic and Nference, seeks new treatments for rare diseases by coupling Mayo research with publicly available genomic data sets.
Pharmacogenomics informatics company OneOme will interpret and package data for Right 10K, a population-based PGx study in the US spearheaded by Mayo Clinic anf Baylor.
The Mayo Medical Laboratories laboratory is offering mate-pair sequencing for cancer and inherited disease indications, with plans to expand the service.
Building off a study that includes preemptive PGx test results in patients' EMRs, researchers want to make that information portable via a scannable card.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
